EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia

Simone Claudiani, Silvia Metelli, Afzal Khan, Guy Hannah, Jenny Byrne, Paolo Gallipoli, Simon J Bulley, Gillian A Horne, Kate Rothwell, Mhairi Copland, Richard E Clark, Fiona Fernando und 3 weitere

British Journal of Haematology · 2026-05 · 208 (5) · 1660-1668

DOI: 10.1111/bjh.70409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 08.03.2026. Verfasst von Simone Claudiani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Inflammation, Faculty of Medicine, Centre for Haematology, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The modern management of chronic myeloid leukaemia (CML) identifies a new therapeutic goal of treatment‐free remission (TFR). Half of CML patients in durable deep molecular response (DMR) (MR 4 or better) can remain off tyrosine kinase inhibitors (TKIs) without experiencing loss of major molecular response. Despite a large number of TFR studies to date, there are no consistent predictors of successful TFR. We conducted a single‐centre cohort study on 197 patients discontinuing TKIs in DMR ≥1 year and TKI therapy ≥3 years. After TKI discontinuation, 98 patients (49.7%) lost MR 4 ; of these, 90 (91.8%; and 45.7% of the whole cohort) lost major molecular response (MMR or MR 3 ) after a median of 3.8 months (1–93.3). The 2‐year probability of TFR (pTFR) was 57.7%. In multivariable analysis, male sex, age at diagnosis >40 years, faster achievement of MR 4 and longer duration of DMR were the only variables significantly associated with higher pTFR. Based on the multivariable analysis results, we built a TFR prognostic score (TPS) able to distinguish three groups with different 2‐year pTFR: good (89.9%), intermediate (61.2%) and poor (18.4%) TFR probability ( p < 0.0001). We validated the TPS on an independent cohort of 91 patients. We propose that the TPS could become a useful guide for CML clinicians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsHumansMaleFemalePrognosisRemission InductionMiddle AgedAdultAgedTreatment InterruptionYoung AdultAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

DMRTFRTKIprognostic score

Substanzen

Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Immunology and Inflammation, Faculty of Medicine, Centre for Haematology, Imperial College London, London, UK.
  • Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Centre of Research in Epidemiology and Statistics (CRESS), University of Paris, INSERM, INRA, Paris, France.
  • Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • Department of Haematology, King's College Hospital, King's College Hospital NHS Foundation Trust, London, UK.
  • Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.

Zitieren

APA

Claudiani, S., Metelli, S., Khan, A., Hannah, G., Byrne, J., Gallipoli, P., Bulley, S. J., Horne, G. A., Rothwell, K., Copland, M., Clark, R. E., Fernando, F., Innes, A. J., Apperley, J. F., & Milojkovic, D. (2026). Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia. British Journal of Haematology, 208(5), 1660-1668. https://doi.org/10.1111/bjh.70409

Vancouver

Claudiani S, Metelli S, Khan A, Hannah G, Byrne J, Gallipoli P, et al. Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia. British Journal of Haematology. 2026;208(5):1660-1668. doi:10.1111/bjh.70409

BibTeX
@article{Claudiani2026,
  author = {Claudiani, Simone and Metelli, Silvia and Khan, Afzal and Hannah, Guy and Byrne, Jenny and Gallipoli, Paolo and Bulley, Simon J and Horne, Gillian A and Rothwell, Kate and Copland, Mhairi and Clark, Richard E and Fernando, Fiona and Innes, Andrew J and Apperley, Jane F and Milojkovic, Dragana},
  title = {Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {5},
  pages = {1660--1668},
  doi = {10.1111/bjh.70409}
}
Kostenlos starten →